gross profit bridgeinconsistent2024-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$2.76B
Fiscal year ended 2025-12-31Operating income
$27.46M
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31ACCENDRA HEALTH INC/VA/ (ACH) reported revenue of $2.76B and net income of -$1.10B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ACCENDRA HEALTH INC/VA/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B | $8.48B | $9.21B | $9.42B | $9.32B | $9.72B |
| Cost of revenue | $1.47B | Unavailable | Unavailable | $8.13B | $8.27B | $7.20B | $8.08B | $8.35B | $8.15B | $8.54B |
| Gross profit | $1.29B | Unavailable | Unavailable | $1.83B | $1.51B | $1.28B | $1.13B | $1.07B | $1.17B | $1.19B |
| Operating income | $27.46M | -$217.73M | $133.23M | $142.91M | $368.47M | $204.12M | $73.15M | -$352.35M | $89.25M | $199.60M |
| Net income | -$1.10B | -$362.69M | -$41.30M | $22.39M | $221.59M | $29.87M | -$62.37M | -$437.01M | $72.79M | $108.79M |
| Research & development | Unavailable | $13.00M | $13.00M | $12.00M | $12.10M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 76.90M | shares 76.74M | shares 77.37M | shares 76.22M | shares 75.49M | shares 63.51M | shares 60.57M | Unavailable | shares 60.00M | shares 61.09M |
| Pretax income | -$101.95M | -$329.88M | $15.26M | $10.89M | $276.75M | $109.91M | -$28.72M | -$427.09M | $57.48M | $172.54M |
| Income tax expense | $729.00K | $20.85M | $6.36M | -$11.50M | $55.16M | $21.83M | -$6.14M | -$32.43M | -$15.32M | $63.76M |
| Diluted EPS | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 | $0.47 | $-1.03 | Unavailable | Unavailable | $1.76 |
| Selling, general & administrative | $1.07B | $1.08B | $1.00B | $1.55B | $1.08B | $1.04B | $1.02B | $952.86M | $1.02B | $970.42M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $281.99M | $27.57M | $243.04M | $69.47M | $55.71M | $83.06M | $67.03M | $66.31M | $104.52M | $185.49M |
| Total assets | $2.45B | $4.66B | $5.09B | $5.39B | $3.54B | $3.34B | $3.64B | $3.77B | $3.38B | $2.72B |
| Current assets | $547.87M | $2.02B | $2.10B | $2.30B | $2.32B | $2.14B | $2.41B | $2.54B | $2.18B | $1.96B |
| Total liabilities | $2.91B | $4.07B | $4.17B | $4.44B | $2.60B | $2.62B | $3.18B | $3.26B | $2.36B | $1.76B |
| Current liabilities | $947.08M | $1.85B | $1.89B | $1.57B | $1.34B | $1.35B | $1.42B | $1.47B | $1.31B | $1.03B |
| Total equity incl. NCI | -$460.98M | $586.36M | $945.30M | $966.74M | $938.50M | $712.05M | $462.15M | $518.42M | $1.02B | $960.04M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $74.44M | $67.58M | $1.11B | $1.33B | $1.50B | $1.23B | $1.15B | $1.27B | $990.19M | $916.31M |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $1.23B | $1.23B | $1.64B | $1.64B | $390.18M | $394.09M | $393.18M | $414.12M | $686.96M | $414.94M |
| Long-term debt | $1.80B | $1.80B | $1.89B | $2.48B | $947.54M | $986.02M | $1.51B | $1.65B | $900.74M | $564.58M |
| Accounts payable | $363.56M | $359.93M | $1.17B | $1.15B | $1.00B | $1.00B | $808.04M | $1.07B | $947.57M | $750.75M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | Unavailable | $161.50M | $740.71M | $325.01M | $124.18M | $339.22M | $166.08M | $115.59M | $56.77M | $187.70M |
| Capital expenditures | $190.96M | $170.29M | $172.38M | $158.09M | $40.98M | $50.42M | $42.42M | $44.87M | $34.61M | $20.30M |
| Investing cash flow | $144.42M | -$116.53M | -$137.25M | -$1.80B | -$53.63M | $80.07M | -$51.90M | -$815.83M | -$416.64M | -$24.75M |
| Financing cash flow | $188.08M | -$267.60M | -$417.33M | $1.50B | -$129.48M | -$379.39M | -$130.20M | $701.07M | $272.81M | -$142.70M |
| Net change in cash | $232.61M | -$223.54M | $186.74M | $14.15M | -$62.47M | $49.82M | -$18.68M | -$1.16M | -$80.97M | $24.47M |
| Stock-based compensation | $12.87M | $16.64M | $14.40M | $20.99M | $25.02M | $20.01M | $15.80M | $16.38M | $11.91M | $12.04M |
| Common dividends paid | Unavailable | Unavailable | $0 | $0 | $731.00K | $648.00K | $5.23M | $48.20M | $63.15M | $63.38M |
| Common share repurchases | $10.18M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $5.00M | $71.03M |
| Depreciation & amortization | $214.52M | $181.28M | $210.37M | $228.67M | $90.62M | $93.34M | $116.68M | $101.93M | $59.44M | $55.39M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | $166.92M | $83.19M | $288.80M | $123.67M | $70.72M | $22.16M | $167.39M |
| Gross margin | 46.7% | Unavailable | Unavailable | 18.3% | 15.5% | 15.1% | 12.3% | 11.4% | 12.6% | 12.2% |
| Operating margin | 1.0% | -8.1% | 5.2% | 1.4% | 3.8% | 2.4% | 0.8% | -3.7% | 1.0% | 2.1% |
| FCF margin | Unavailable | Unavailable | Unavailable | 1.7% | 0.9% | 3.4% | 1.3% | 0.8% | 0.2% | 1.7% |
| SBC / revenue | 0.5% | 0.6% | 0.6% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% |
| Current ratio | 0.58x | 1.09x | 1.11x | 1.47x | 1.73x | 1.59x | 1.70x | 1.72x | 1.67x | 1.90x |
| Revenue YoY growth | 3.1% | 5.0% | -74.4% | 1.7% | 15.4% | -7.9% | -2.2% | 1.1% | -4.2% | Unavailable |
| Net margin | -39.8% | -13.5% | -1.6% | 0.2% | 2.3% | 0.4% | -0.7% | -4.6% | 0.8% | 1.1% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | 0.1% | 0.1% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 6.9% | 6.4% | 6.8% | 1.6% | 0.4% | 0.6% | 0.5% | 0.5% | 0.4% | 0.2% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | 41.7% | -105.6% | 19.9% | 19.9% | Unavailable | Unavailable | -26.6% | 37.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-20View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Companies in the same industry
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2023-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
balance equationreview2023-12-31
Difference 21138000 exceeds tolerance 5093322.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 21138000 exceeds tolerance 5386283.000. Presentation or filing-vintage differences need review.